Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3M4 in Persons With HIV-1 Suppressed on ART
Clinical trial NCT05604209 · COMPLETED
Trial details
- NCT number
- NCT05604209
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-13
- Primary completion
- 2024-09-12
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.